Hepatoprotective and Antioxidant Capacity of Mallotus repandus Ethyl Acetate Stem Extract against D-Galactosamine-Induced Hepatotoxicity in Rats

Mallotus repandus (M. repandus) is traditionally used to treat muscle pain, itching, fever, rheumatic arthritis, and a variety of liver disorders. The aim of the present work was to evaluate the hepatoprotective activity and the antioxidant potential of the ethyl acetate stem extract of M. repandus (ESMR) against D-galactosamine (D-GalN)-induced hepatopathy, along with a possible mechanism of action in rats. In vivo hepatoprotective activity of ESMR was examined using D-galactosamine (D-GalN)-induced hepatotoxicity in Sprague-Dawley rats. For this purpose, levels of serum diagnostic markers, activity of hepatic antioxidant enzymes, and liver histo-architecture were employed to assess the protective efficacy of ESMR. Furthermore, the total phenolic, flavonoid, and tannin contents were quantitated, and the antioxidant capacity of the extract was evaluated using different methods such as 2,2'-diphenyl-1-picrylhydrazyl (DPPH), nitric oxide (NO), hydrogen peroxide (H2O2), and hydroxyl radical (OH center dot) scavenging assays. Intraperitoneal D-GalN injection triggered hepatotoxicity, as shown by the noticeable increase in the serum hepatic marker enzymes, bilirubin content, gamma-glutamyl transferase (GGT), total cholesterol (TC), triglycerides (TGs), and malondialdehyde (MDA), whereas glutathione, superoxide dismutase, and catalase levels were significantly lower compared with that of the control. Pretreatment with ESMR reduced the hepatic enzyme levels along with bilirubin, GGT, and MDA compared to the D-GalN-intoxicated group. These results were supported by histopathological studies, where D-galactosamine caused coagulative necrosis, hemorrhage, and inflammation. However, pretreatment with ESMR ameliorated the histo-architectural changes and brought them back to normal. Results also revealed that the total polyphenolic, flavonoid, and tannin content, and total antioxidant capacity of ESMR were 136.30 +/- 0.78 mg GAE/g mg, 38.72 +/- 0.85 mg QE/g, 75.88 +/- 0.54 mg TAE/g, and 123.16 +/- 0.24 mg AAE/g, respectively. In addition, ESMR inhibited free radicals with IC50 values of 94.47 +/- 0.51, 127.33 +/- 0.36, 164.12 +/- 0.45, and 254.14 +/- 0.35 mu g/mL in DPPH, NO, H2O2, and OH center dot free radical scavenging assays, respectively. These findings highlight the protective role of ESMR against hepatic injury induced by D-GalN, which may be attributed to its higher antioxidant properties, thereby scientifically justifying its traditional use.